Results 11 to 20 of about 1,232,228 (310)

malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication.

open access: yesPLoS Medicine, 2017
Resistance to first-line treatments for Plasmodium falciparum malaria and the insecticides used for Anopheles vector control are threatening malaria elimination efforts. Suboptimal responses to drugs and insecticides are both spreading geographically and
malERA Refresh Consultative Panel on Insecticide and Drug Resistance
doaj   +1 more source

Drug Resistance in Leishmaniasis [PDF]

open access: yesJournal of Global Infectious Diseases, 2010
The treatment options of leishmaniasis are limited and far from satisfactory. For more than 60 years, treatment of leishmaniasis has centered around pentavalent antimonials (Sb(v)). Widespread misuse has led to the emergence of Sb(v) resistance in the hyperendemic areas of North Bihar. Other antileishmanials could also face the same fate, especially in
Shyam Sundar, Jaya Chakravarty
openaire   +4 more sources

Drivers and sites of diversity in the DNA adenine methylomes of 93 Mycobacterium tuberculosis complex clinical isolates

open access: yeseLife, 2020
This study assembles DNA adenine methylomes for 93 Mycobacterium tuberculosis complex (MTBC) isolates from seven lineages paired with fully-annotated, finished, de novo assembled genomes. Integrative analysis yielded four key results.
Samuel J Modlin   +9 more
doaj   +1 more source

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma

open access: yesPharmaceuticals, 2021
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the deadliest tumors worldwide. The diagnosis is often possible only in the latter stages of the disease, with patients already presenting an advanced or metastatic tumor. It is also one of the
Rita Rebelo   +4 more
doaj   +1 more source

Drug resistance and combating drug resistance in cancer

open access: yesCancer Drug Resistance, 2019
Cancer is the second leading cause of death in the US. Current major treatments for cancer management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy, endocrine therapy and immunotherapy. Despite the endeavors and achievements made in treating cancers during the past decades, resistance to classical chemotherapeutic agents ...
Xiaozhuo Chen, Haiyun Zhang, Xuan Wang
openaire   +3 more sources

Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study

open access: yesFrontiers in Oncology, 2023
BackgroundDue to the lack of strong evidence-based medical evidence, the relationship between autologous breast reconstruction (ABR) after mastectomy and long-term prognosis is unclear.
Shang Wu   +11 more
doaj   +1 more source

Resisting Bacterial Drug Resistance [PDF]

open access: yesChemistry & Biology, 2003
In this issue of Chemistry & Biology, Wright and colleagues report an elegant method for inhibiting enzymes critical for rendering bacteria drug resistant. By using cationic peptides as inhibitors, the authors have exploited two antibacterial mechanisms, making it doubly difficult for microbial retaliation.
openaire   +3 more sources

Drug resistant tuberculosis [PDF]

open access: yesBMJ, 1995
EDITOR,—Concern is growing over the spread of drug resistant Mycobacterium tuberculosis. New evidence suggests that this spread may be increasing in certain sections of the British population. The recent advances in molecular techniques have equipped us with the means to make substantial inroads into the possible impact of drug resistant tuberculosis.1
openaire   +6 more sources

The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?

open access: yesBiomedicines, 2023
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of neoplastic B lymphocytes that escape death, and correlates with the expression of negative prognostic markers such as the CD38 antigen.
Brigitte Bauvois   +5 more
doaj   +1 more source

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis

open access: yesMicrobiology Spectrum, 2023
Clofazimine (CFZ) has been repurposed for treating tuberculosis (TB), especially multidrug-resistant tuberculosis (MDR-TB). However, the mechanisms of resistance to clofazimine are poorly understood.
Lei Zhang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy